Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Recapitulating X-Linked Juvenile Retinoschisis in Mouse Model by Knock-In Patient-Specific Novel Mutation
Ding Chen1,2, Tao Xu1,2, Mengjun Tu1,2
1State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Abstract:
X-linked juvenile retinoschisis (XLRS) is a retinal disease caused by mutations in the gene encoding retinoschisin (RS1), which leads to a significant proportion of visual impairment and blindness. To develop personalized genome editing based gene therapy, knock-in animal disease models that have the exact mutation identified in the patients is extremely crucial, and that the way which genome editing in knock-in animals could be easily transferred to the patients. Here we recruited a family diagnosed with XLRS and identified the causative mutation (RS1, p.Y65X), then a knock-in mouse model harboring this disease-causative mutation was generated via TALEN (transcription activator-like effector nucleases). We found that the b-wave amplitude of the ERG of the RS1-KI mice was significantly decreased. Moreover, we observed that the structure of retina in RS1-KI mice has become disordered, including the disarray of inner nuclear layer and outer nuclear layer, chaos of outer plexiform layer, decreased inner segments of photoreceptor and the loss of outer segments. The novel knock-in mice (RS1-KI) harboring patient-specific mutation will be valuable for development of treatment via genome editing mediated gene correction.
Insights
Researchers created a new mouse model for X-linked juvenile retinoschisis (XLRS) with a patient-specific mutation. This RS1-KI mouse model shows retinal degeneration and will aid in developing gene therapies for XLRS.
Area of Science:
- Genetics
- Ophthalmology
- Molecular Biology
Background:
- X-linked juvenile retinoschisis (XLRS) is a genetic retinal disorder caused by mutations in the RS1 gene.
- XLRS leads to significant visual impairment and blindness, necessitating effective therapeutic strategies.
- Developing patient-specific animal models is crucial for advancing gene therapy research.
Purpose of the Study:
- To generate a knock-in mouse model harboring the specific p.Y65X mutation identified in a patient family with XLRS.
- To characterize the retinal phenotype and electroretinographic (ERG) abnormalities in the generated RS1-KI mice.
- To establish a valuable preclinical tool for developing genome editing-based gene therapies for XLRS.
Main Methods:
- Recruitment of an XLRS patient family and identification of the causative RS1 mutation (p.Y65X).
- Generation of a knock-in mouse model (RS1-KI) using TALEN technology to introduce the patient-specific mutation.
- Assessment of retinal structure and function using electroretinography (ERG) and histological analysis.
Main Results:
- The RS1-KI mice exhibited significantly decreased b-wave amplitudes in ERG recordings, indicating impaired retinal function.
- Histological examination revealed retinal structural abnormalities in RS1-KI mice, including disorganization of nuclear layers and photoreceptor degeneration.
- The generated knock-in model accurately recapitulates key pathological features of human XLRS.
Conclusions:
- The novel RS1-KI mouse model carrying the patient-specific p.Y65X mutation is successfully generated.
- This model demonstrates functional and structural retinal deficits consistent with XLRS.
- The RS1-KI mice serve as a valuable preclinical platform for evaluating genome editing strategies for XLRS treatment.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Viral Mutations
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Mutation, Gene Flow, and Genetic Drift

